Conference
Association between progression-free survival and health-related quality of life in oncology: A systematic review and regression analysis.
Abstract
6574
Background: The goal of cancer care is to improve not only survival duration but also health-related quality of life (HRQoL). Progression-free survival (PFS) has become an important surrogate outcome in assessing efficacy of new cancer drugs, but the relationship between improved PFS and HRQoL is not clear, particularly in the absence of an overall survival (OS) benefit. The objective of this study was to examine the …
Authors
Kovic B; Jin X; Thabane L; Guyatt G; Brundage MD; Xie F
Volume
35
Pagination
pp. 6574-6574
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2017
DOI
10.1200/jco.2017.35.15_suppl.6574
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X